Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials

AC Ford, L Peyrin-Biroulet - … journal of the American College of …, 2013 - journals.lww.com
OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …
被引用次数：376 相关文章

Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials

AC Ford, L Peyrin-Biroulet - The American journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Objectives Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …

Opportunistic Infections With Anti-Tumor Necrosis Factor-[alpha] Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

AC Ford, L Peyrin-biroulet - The American Journal of …, 2013 - search.proquest.com
OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

A Ford, L Peyrin-Biroulet - The American Journal of …, 2013 - hal.univ-lorraine.fr
OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …

Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.

AC Ford, L Peyrin-Biroulet - The American Journal of …, 2013 - europepmc.org
Objectives Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …

Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.

AC Ford, L Peyrin-Biroulet - 2013 - cabidigitallibrary.org
OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …

[引用][C] Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

AC Ford, L Peyrin-Biroulet - American Journal of Gastroenterology, 2013 - cir.nii.ac.jp
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel
Disease: Meta-Analysis of Randomized Controlled Trials | CiNii Research CiNii 国立情報学 …

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

A Ford, L Peyrin-Biroulet - The American Journal of Gastroenterology, 2013 - hal.science
OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials.

AC Ford, L Peyrin-Biroulet - American Journal of …, 2013 - search.ebscohost.com
OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated
efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the …